Tech Company Financing Transactions
TARA Biosystems Funding Round
TARA Biosystems closed a $10 million Series A venture capital round on 6/24/2020. Investors included Alexandria Venture Investments, DEFTA Partners and Lifeforce Ventures.
Transaction Overview
Company Name
Announced On
6/24/2020
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Proceeds Purpose
This financing will be used to scale TARA's cardiac tissue engineering platform technology and advance its drug discovery programs.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
430 East 29th St. 1015
New York, NY 10016
USA
New York, NY 10016
USA
Phone
Undisclosed
Website
Email Address
Overview
TARA Biosystems, Inc. provides predictive, in vitro human cardiac tissue models for use in drug discovery and safety assessment. TARA's cardiac tissues are produced from human induced pluripotent stem cell-derived cardiomyocytes, matured to an adult-like phenotype, and interrogated to provide direct measures of cardiac functionality, including contractile force.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Misti Ushio
Chief Scientific Officer
Michael Graziano
VP - Finance
Steven Lesiak
VP - R & D
Rooz Sobbi
Browse more venture capital transactions:
Prev: 6/24/2020: Blue Studios venture capital transaction
Next: 6/24/2020: Immuta venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs